For its fourth fiscal quarter (ending December 31), STAAR Surgical Co (NASDAQ: STAA) has reported a -531% decline in E.P.S. from $0.16 a year ago to $-0.69 in the current quarter. This performance was $-0.69 short of the consensus estimate of $-0.00. E.P.S. were $-0.41 for the latest four quarters through December 31 versus $0.44 for the same period a year ago — a decline of -193%.
Recent Price Action
On 2/11/25, STAAR Surgical Co (NASDAQ: STAA) stock declined by -3.2%, closing at $21.88. NORMAL trading volume accompanied the decline. Relative to the market the stock has been extremely weak over the last nine months and has declined -6.4% during the last week.
Current PriceTarget Research Rating
STAAR Surgical has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects complementary signals from PTR’s two proprietary measures of a stock’s attractiveness. STAAR Surgical has a slightly negative Appreciation Score of 32 and a very low Power Rating of 7, resulting in the Lowest Value Trend Rating.
Rating Review
In light of this discouraging new earnings information and negative market action we are reviewing our current Overall Rating of F. We would continue to view the shares with caution pending completion of this review in the next several days.
Be the first to comment